Loading: 100%
MCKESSON CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 78,000 (as per FY 2017)no data available
Sector Medical Distribution, HealthcareMedical Distribution, Healthcareno data available
Ticker MCKno data available
Financial year endsFY ends End of Marchno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17120135150165180
datesClosing price (adj.)
13.10.2017147.17
11.10.2017149.94
04.10.2017153.61
27.09.2017155.95
20.09.2017150.18
13.09.2017157.68
06.09.2017152.09
30.08.2017146.70
23.08.2017146.85
16.08.2017147.30
09.08.2017153.91
02.08.2017159.24
26.07.2017165.97
19.07.2017164.47
12.07.2017165.96
05.07.2017164.89
27.06.2017166.30
20.06.2017160.60
13.06.2017161.78
06.06.2017161.57
30.05.2017161.46
23.05.2017158.37
16.05.2017144.34
09.05.2017141.92
02.05.2017138.65
25.04.2017134.46
18.04.2017137.05
11.04.2017144.80
04.04.2017145.19
28.03.2017149.28
21.03.2017145.42
14.03.2017146.52
07.03.2017146.65
28.02.2017149.53
21.02.2017150.01
14.02.2017144.35
07.02.2017139.11
31.01.2017138.34
24.01.2017147.45
17.01.2017147.56
10.01.2017145.96
03.01.2017146.57
27.12.2016141.24
19.12.2016140.73
12.12.2016145.64
05.12.2016144.15
28.11.2016141.99
21.11.2016140.25
14.11.2016142.57
07.11.2016133.46
31.10.2016126.18
24.10.2016159.02
17.10.2016159.40
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
147.17n/a
Market Capitalisation
in million USD
31,208n/a
Enterprise Value
in million USD
35,366n/a
Common Shares Outstanding
as per Dec 31, 2016
212,052,504n/a
Preferred Shares Outstanding
as per Dec 31, 2016
n/a
Average Basic Shares Outstanding
TTM
221,000,000n/a
Average Diluted Shares Outstanding
TTM
223,000,000n/a
Index Membership
n/a
Business Summary
McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 194,267n/a
Gross Profit 11,387n/a
Operating Income 3,705n/a
EBITDA 4,598n/a
Net Profit 1,914n/a
Balance Sheet
Cash and Cash Equivalents 5,464n/a
Receivables 18,308n/a
Total Current Assets 41,338n/a
PP&E 2,300n/a
Total Assets 58,315n/a
Accounts Payable 31,037n/a
Current Debt 2,166n/a
Total Current Liabilities 37,051n/a
Long-Term Debt 5,941n/a
Total Liabilities 47,348n/a
Total Equity 10,967n/a
Cash Flow
Depreciation & Amortisation 893n/a
Change in Working Capital 1,775n/a
Operating Cash Flow 5,349n/a
Net Change in PP&E and Intangibles -461n/a
Investing Cash Flow -2,834n/a
Dividends Paid -259n/a
Financing Cash Flow -2,377n/a
Total Change in Cash 105n/a
Free Cash Flow 5,065n/a
Profitability Ratios
Gross Margin 5.9%n/a
Operating Margin 1.9%n/a
Net Profit Margin 1.0%n/a
Return on Equity 18.0%n/a
Return on Assets 3.4%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 7.69n/a
EV/Sales 0.18n/a
Book to Market Value 0.35n/a
Other Ratios
Current Ratio 111.6%n/a
Liabilities to Equity Ratio 431.7%n/a
Debt to Assets Ratio 13.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
101,703
106,632
108,702
112,084
122,321
122,196
137,392
179,045
190,884
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-96,694
-101,254
-103,026
-106,114
-115,919
-115,315
-129,040
-167,634
-179,468
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
5,009
5,378
5,676
5,970
6,402
6,881
8,352
11,411
11,416
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-3,536
-3,689
-3,688
-3,936
-4,129
-4,543
-5,845
-8,293
-7,668
Selling, General & Administrative
-3,189
-3,325
-3,312
-3,529
-3,727
-4,110
-5,388
-7,901
-7,276
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-347
-364
-376
-407
-402
-433
-457
-392
-392
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
1,473
1,689
1,988
2,034
2,273
2,338
2,507
3,118
3,748
Non-Operating Income (Loss)
-21
-132
-144
-186
-231
-206
-268
-311
-295
Interest Expense, net
-142
-144
-187
-222
-251
-240
-300
-374
-353
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
121
12
43
36
20
34
32
63
58
Pretax Income (Loss), Adjusted
1,452
1,557
1,844
1,848
2,042
2,132
2,239
2,807
3,453
Abnormal Gains (Losses)
5
-493
20
-213
-149
-182
-68
-150
-203
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
1,457
1,064
1,864
1,635
1,893
1,950
2,171
2,657
3,250
Income Tax (Expense) Benefit, net
-468
-241
-601
-505
-514
-587
-757
-815
-908
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
989
823
1,263
1,130
1,379
1,363
1,414
1,842
2,342
Net Extraordinary Gains (Losses)
1
0
0
72
24
-25
-156
-299
-32
Discontinued Operations
1
0
0
72
24
-25
-156
-299
-32
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
990
823
1,263
1,202
1,403
1,338
1,258
1,543
2,310
Minority Interest
0
0
0
0
0
0
5
-67
-52
Net Income
990
823
1,263
1,202
1,403
1,338
1,263
1,476
2,258
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
990
823
1,263
1,202
1,403
1,338
1,263
1,476
2,258
Remarks
restated on May 4, 2010 n/a
calculated values,
restated on May 5, 2011 n/a
calculated values,
restated on May 2, 2012 n/a
calculated values,
restated on May 7, 2013 n/a
calculated values,
restated on May 14, 2014 n/a
calculated values,
restated on May 12, 2015 n/a
calculated values,
restated on May 5, 2016 n/a
calculated values,
restated on May 22, 2017 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
2,109
3,731
3,612
3,149
2,456
4,193
5,341
4,048
Cash & Cash Equivalents
n/a
2,109
3,731
3,612
3,149
2,456
4,193
5,341
4,048
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
7,774
8,075
9,187
9,977
9,975
13,780
15,914
17,980
Accounts Receivable, Net
n/a
7,774
8,075
9,187
9,977
9,975
13,780
15,914
17,980
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
8,527
9,441
9,225
10,073
10,335
12,986
14,296
15,335
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
261
257
333
404
404
1,877
1,119
1,072
Prepaid Expenses
n/a
261
257
333
404
404
1,877
1,119
437
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
635
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
18,671
21,504
22,357
23,603
23,170
32,836
36,670
38,435
Property, Plant & Equipment, Net
n/a
796
851
991
1,043
1,321
2,196
2,045
2,278
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
5,800
5,834
7,538
8,447
10,295
16,727
15,155
15,810
Intangible Assets
n/a
661
551
1,456
1,750
2,270
4,871
3,441
3,021
Goodwill
n/a
3,528
3,568
4,364
5,032
6,405
9,927
9,817
9,786
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1,611
1,715
1,718
1,665
1,620
1,929
1,897
3,003
Total Noncurrent Assets
n/a
6,596
6,685
8,529
9,490
11,616
18,923
17,200
18,088
Total Assets
n/a
25,267
28,189
30,886
33,093
34,786
51,759
53,870
56,523
Liabilities and owners' equity
Payables & Accruals
n/a
14,242 14242000000
14,814 14814000000
15,951 15951000000
18,263 18263000000
18,020 18020000000
25,126 25126000000
28,935 28935000000
31,880 31880000000
Accounts Payable
n/a
11,739 11739000000
13,255 13255000000
14,090 14090000000
16,114 16114000000
16,108 16108000000
21,128 21128000000
25,166 25166000000
28,585 28585000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
2,503 2503000000
1,559 1559000000
1,861 1861000000
2,149 2149000000
1,912 1912000000
3,998 3998000000
3,769 3769000000
3,295 3295000000
Short Term Debt
n/a
219 219000000
3 3000000
417 417000000
908 908000000
352 352000000
1,665 1665000000
1,664 1664000000
1,610 1610000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1,145 1145000000
2,195 2195000000
2,358 2358000000
2,515 2515000000
2,985 2985000000
2,824 2824000000
2,898 2898000000
1,579 1579000000
Deferred Revenue
n/a
1,145 1145000000
1,218 1218000000
1,321 1321000000
1,423 1423000000
1,359 1359000000
1,236 1236000000
1,078 1078000000
919 919000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
977 977000000
1,037 1037000000
1,092 1092000000
1,626 1626000000
1,588 1588000000
1,820 1820000000
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
660 660000000
Total Current Liabilities
n/a
15,606 15606000000
17,012 17012000000
18,726 18726000000
21,686 21686000000
21,357 21357000000
29,615 29615000000
33,497 33497000000
35,069 35069000000
Long Term Debt
n/a
2,290 2290000000
2,293 2293000000
3,587 3587000000
3,072 3072000000
4,521 4521000000
8,929 8929000000
8,180 8180000000
6,497 6497000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
1,170 1170000000
1,340 1340000000
1,363 1363000000
1,508 1508000000
1,852 1852000000
2,920 2920000000
2,715 2715000000
4,541 4541000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
859 859000000
2,734 2734000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1,170 1170000000
1,340 1340000000
1,363 1363000000
1,508 1508000000
1,852 1852000000
2,920 2920000000
1,856 1856000000
1,807 1807000000
Total Noncurrent Liabilities
n/a
3,460 3460000000
3,633 3633000000
4,950 4950000000
4,580 4580000000
6,373 6373000000
11,849 11849000000
10,895 10895000000
11,038 11038000000
Total Liabilities
n/a
19,066 19066000000
20,645 20645000000
23,676 23676000000
26,266 26266000000
27,730 27730000000
41,464 41464000000
44,392 44392000000
46,107 46107000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
4,421 4421000000
4,760 4760000000
5,343 5343000000
5,575 5575000000
6,082 6082000000
6,556 6556000000
6,972 6972000000
5,848 5848000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-4,144 -4144000000
-4,458 -4458000000
-6,470 -6470000000
-8,204 -8204000000
-9,363 -9363000000
-9,507 -9507000000
-9,956 -9956000000
-3,721 -3721000000
Retained Earnings
n/a
6,103 6103000000
7,236 7236000000
8,250 8250000000
9,451 9451000000
10,402 10402000000
11,453 11453000000
12,705 12705000000
8,360 8360000000
Other Equity
n/a
-179 -179000000
6 6000000
87 87000000
5 5000000
-65 -65000000
-3 -3000000
-1,713 -1713000000
-1,561 -1561000000
Equity Before Minority Interest
n/a
6,201 6201000000
7,544 7544000000
7,210 7210000000
6,827 6827000000
7,056 7056000000
8,499 8499000000
8,008 8008000000
8,926 8926000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
1,796 1796000000
1,470 1470000000
1,494 1494000000
Total Equity
n/a
6,201 6201000000
7,544 7544000000
7,210 7210000000
6,827 6827000000
7,056 7056000000
10,295 10295000000
9,478 9478000000
10,420 10420000000
Total Liabilities & Equity
n/a
25,267 25267000000
28,189 28189000000
30,886 30886000000
33,093 33093000000
34,786 34786000000
51,759 51759000000
53,870 53870000000
56,527 56527000000
Remarks restated on n/a restated on May 4, 2010 n/a restated on May 5, 2011 n/a restated on May 2, 2012 n/a restated on May 7, 2013 n/a restated on May 14, 2014 n/a restated on May 12, 2015 n/a restated on May 5, 2016 n/a restated on Oct 27, 2016 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
989
823
1,263
1,130
1,403
1,338
1,258
1,543
2,310
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
371
441
474
496
493
581
735
1,017
885
Non-Cash Items
218
585
368
452
407
452
749
949
380
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
253
-646
561
286
673
595
499
-397
97
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
1,831
1,203
2,666
2,364
2,976
2,966
3,241
3,112
3,672
Change in Fixed Assets & Intangibles
-195
-195
-199
-233
-221
-241
-278
-376
-488
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-610
-295
-17
-183
-1,051
-1,873
-4,537
-155
170
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-162
-237
-443
-234
-256
-578
-336
-146
-1,239
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-967
-727
-659
-650
-1,528
-2,692
-5,151
-677
-1,557
Dividends Paid
-70
-116
-131
-171
-195
-194
-214
-227
-244
Cash From (Repayment of) Debt
-162
695
-219
-41
-30
255
3,724
-402
-1,725
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-1,344
97
-111
-1,683
-1,707
-1,048
47
-298
-1,489
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
106
4
40
54
27
31
62
-41
5
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-1,470
680
-421
-1,841
-1,905
-956
3,619
-968
-3,453
Net Cash Before Disc. Operations and FX
-606
1,156
1,586
-127
-457
-682
1,709
1,467
-1,338
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-606
1,156
1,586
-127
-457
-682
1,709
1,467
-1,338
Effect of Foreign Exchange Rates
14
-55
36
8
-6
-11
28
-319
45
Net Changes in Cash
-592
1,101
1,622
-119
-463
-693
1,737
1,148
-1,293
Remarks
restated on May 4, 2010 n/a
calculated values,
restated on May 5, 2011 n/a
calculated values,
restated on May 2, 2012 n/a
calculated values,
restated on May 7, 2013 n/a
calculated values,
restated on May 14, 2014 n/a
calculated values,
restated on May 12, 2015 n/a
calculated values,
restated on May 5, 2016 n/a
calculated values,
restated on May 5, 2016 n/a
calculated values,
restated on May 22, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo